Date | Time | Source | Headline | Symbol | Company |
05/08/2024 | 1:05PM | iHub Newswire | FeaturedElement79 Gold Corp Successfully Closes Maverick Springs Option Agreement | | |
02/14/2024 | 2:51PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:MRTX | Mirati Therapeutics Inc |
02/14/2024 | 9:13AM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:MRTX | Mirati Therapeutics Inc |
02/02/2024 | 4:05PM | Edgar (US Regulatory) | Form 15-12G - Securities registration termination [Section 12(g)] | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/25/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/25/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/25/2024 | 12:15AM | Edgar (US Regulatory) | Form EFFECT - Notice of Effectiveness | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:38PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:37PM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:31AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:31AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:31AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:31AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:31AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:31AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:30AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:30AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:30AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:30AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:30AM | Edgar (US Regulatory) | Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:30AM | Edgar (US Regulatory) | Form POSASR - Post-effective Amendment to an automatic shelf registration statement | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:28AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:27AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 9:17AM | Edgar (US Regulatory) | Form POS AM - Post-Effective amendments for registration statement | NASDAQ:MRTX | Mirati Therapeutics Inc |
01/23/2024 | 8:48AM | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:MRTX | Mirati Therapeutics Inc |